Sector Focus

Biotechnology

Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.

Clients

Sugen, Inc. (now Pfizer)

Sugen, Inc. was a biopharmaceutical company that discovered and developed small molecule drugs used for diseases such as cancer and diabetes, as well as dermatologic, ophthalmic, neurological and immune disorders. The company used crystallographic analysis and computational chemistry in its drug discovery process. Pharmacia acquired SUGEN in 1999.

Search Projects

  • Vice President, Research